Evaluating the Possibility of Diabetes Mellitus in Different Levels of Cardiovascular Risk in Men
This paper evaluated the possibility of diabetes mellitus (DM) type 2 in men with different risks of cardiovascular disease, as well as clarified the relationship between high risk of DM type 2 and the main factors of cardiovascular risk. Respondents (n = 152) were divided into groups of cardiovascular risk without clinical manifestations of cardiovascular diseases. In a cohort of men with different levels of cardiovascular risk by SCORE (Systematic COronary Risk Evaluation) scale, low risk of DM was in 27 % of cases, moderately increased risk — in 34.2% of individuals. Very high risk of DM was in 38.9 % of men. The possibility of DM in the next 10 years, by the Finnish Diabetes Risk Score (FINDRISC) questionnaire, increases with an increase in cardiovascular risk. In the group of low/moderate cardiovascular risk — one in ten males, in the group of high cardiovascular risk — one in three men and in the group of very high cardiovascular risk — every second male has a risk of DM. The increase in predicted risk of DM, by the FINDRISC scale, is associated with an increase of the insulin resistance (IR) index. Among those with IR, 3.9 % are patients with low-risk of DM, 17.7 % belong to the group of moderately increased risk of DM. At the same time, 78.4 % of patients with IR have high and very high risk of DM.
Full Text:PDF (Українська)
Міжнародна діабетична федерація (IDF), сайт. — Режим доступу: http://www.idf.org/diabetesatlas/update-2014
Довідник основних показників діяльності ендокринологічної служби України за 2014 рік // Ендокринологія. — 2015. — Додаток 1. — Т. 20, № 1. — 38 с.
Shah A.D., Langenberg C., Rapsomaniki E. et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 19 million people // Lancet Diabetes Endocrinol. — 2015. — Vol. 3(2). — P. 105-113. doi: 10.1016/S2213-8587(14)70219-0.
Rydén L., Grant P.J., Anker S.D. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) // Eur. Heart J. — 2013. — Vol. 34. — P. 3035-3087.
Bhowmik B., Afsana F., My Diep L. et al. Increasing prevalence of type 2 diabetes in a rural bangladeshi population: a population based study for 10 years // Diabetes Metab. J. — 2013. — Vol. 37(1). — P. 46-53. doi: 10.4093/dmj. 2013.37.1.46.
Singh S.K. Post-prandial hyperglycemia // Indian J. Endocrinol. Metab. — 2012. — Vol. 16 (Suppl. 2). — S245-S247. doi: 10.4103/2230-8210.104051.
Bonora E., Corrao G., Bagnardi V. et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus // Diabetologia. — 2006. — Vol. 49(5). — P. 846-854.
Tuomilehto J., Schwarz P., Lindström J. Long-term be-nefits from lifestyle interventions for type 2 diabetes prevention. Time to expand the efforts // Diabetes Care. — 2011. — Vol. 34 (Suppl. 2). — S210-S214. doi: 10.2337/dc11-s222.
Musso G. The Finnish Diabetes Risk Score (FINDRISC) and other non-invasive scores for screening of hepatic steatosis and associated cardiometabolic risk. // Ann. Med. — 2011. — Vol. 43. — P. 413-417.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2018